Wang G. et al. developed oncolytic adenovirus (oAds) with CXCL11 to reverse the immunosuppressive tumor microenvironment and enhance infiltration of CAR T-cells targeting B7-H3 in glioblastoma. Here, CD276 is linked to glioblastoma.